RDMD's mission is to empower patients and communities to accelerate the development of treatments for rare diseases of all kinds.
We are a medical data science company that helps to identify patients and generate regulatory-grade evidence to enable drug approvals and real world evidence in rare disease.
RDMD is privately funded by Lux Capital and Village Global, a venture capital firm with a network of LPs including Reid Hoffman, Bill Gates, Mark Zuckerberg, and Jeff Bezos.
Read about our mission at www.rdmd.com